Chemotherapy in the management of intraocular lymphoma
- 15 May 1989
- Vol. 63 (10) , 1918-1921
- https://doi.org/10.1002/1097-0142(19890515)63:10<1918::aid-cncr2820631008>3.0.co;2-d
Abstract
Six patients with intraocular (vitreous) lymphomas were treated with high-dose intravenous cytosine arabinoside (Ara-C). Four patients were previously untreated, one patient had previously received ocular and central nervous system radiation therapy and relapsed, and one patient had previously received chemotherapy for systemic lymphoma. Five responses were observed: one complete and four partial. High-dose Ara-C is active in intraocular (vitreous) lymphoma, but complete response is uncommon. Adjunctive use of Ara-C in combination with ocular irradiation may be a useful form of therapy in this uncommon lymphoma.This publication has 20 references indexed in Scilit:
- Treatment of intraocular lymphoma with high-dose Ara-CCancer, 1986
- Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid.Journal of Clinical Oncology, 1983
- Ocular Reticulum Cell SarcomaArchives of Ophthalmology (1950), 1981
- Update of Ocular Reticulum Cell SarcomaArchives of Ophthalmology (1950), 1981
- Ocular Reticulum Cell SarcomaAmerican Journal of Ophthalmology, 1981
- Primary Reticulum Cell Sarcoma of the RetinaPublished by S. Karger AG ,1980
- Reclassification of Intraocular Reticulum Cell Sarcoma (Histiocytic Lymphoma)Archives of Ophthalmology (1950), 1980
- The role of radiation therapy in the management of ocular reticulum cell sarcomaCancer, 1980
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971
- Malignant Lymphoma of the Uveal Tract⋆American Journal of Ophthalmology, 1951